León-Letelier, Ricardo A.Chen, YihuiBallaro, RiccardoIrajizad, EhsanDo, Kim-AnMaitra, AnirbanZhang, JianjunSchmidt, C. MaxFahrmann, Johannes F.2025-02-252025-02-252024León-Letelier RA, Chen Y, Ballaro R, et al. A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi:10.33696/cancerimmunol.6.095https://hdl.handle.net/1805/45991en-USPublisher PolicyPancreatic ductal adenocarcinoma (PDAC)Cancer-related deathsLocalized diseaseMetastaticA Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic CancerArticle